Source:http://linkedlifedata.com/resource/pubmed/id/19694557
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2009-12-16
|
pubmed:abstractText |
Excessive angiogenesis mediated by vascular endothelial growth factor (VEGF) plays an important role in angioproliferative ocular diseases. We have previously developed a large animal model for these diseases by intravitreal adenoviral gene transfer of VEGF-A(165). 15-Lipoxygenase-1 (15-LO-1), an oxidizing enzyme producing reactive lipid hydroperoxides, has been shown to induce aberrant angiogenesis in cancer models of transgenic mice overexpressing human 15-LO-1. Our purpose was to study the effects of 15-LO-1 on VEGF-A(165)-induced angiogenesis in New Zealand White rabbit eyes, using intravitreal adenovirus-mediated gene transfers. AdCMV and Adh15-LO-1 alone served as controls. As determined by immunohistochemistry, VEGF-A(165) significantly increased the number and size of the capillaries in various compartments of the eyes. 15-LO-1 efficiently inhibited VEGF-A(165)-induced neovascularization and pathological changes by reducing VEGF-A(165) mRNA and protein expression, determined by RT-PCR, ELISA, and immunohistochemistry. 15-LO-1, which produces endogenous ligands for peroxisome proliferator-activated receptor-gamma (PPARgamma), also prevented VEGF-A(165)-induced expression of PPARgamma and VEGF receptor-2, as measured by quantitative RT-PCR. In conclusion, our findings show that 15-LO-1 prevents VEGF-A(165)-induced angiogenesis and consequent pathology in the eyes, suggesting that intravitreal 15-LO-1 gene transfer could be a potential new strategy for the treatment of neovascular complications in the eyes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ALOX15 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonate 15-Lipoxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1557-7422
|
pubmed:author |
pubmed-author:BabuMohanM,
pubmed-author:ErikssonEmmiE,
pubmed-author:HeikuraTommiT,
pubmed-author:KalesnykasGiedriusG,
pubmed-author:KinnunenKatiK,
pubmed-author:LähteenvuoJohannaJ,
pubmed-author:LaidinenSvetlanaS,
pubmed-author:TakaloTeemuT,
pubmed-author:ViitaHelenaH,
pubmed-author:Ylä-HerttualaSeppoS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1679-86
|
pubmed:meshHeading |
pubmed-meshheading:19694557-Adenoviridae,
pubmed-meshheading:19694557-Animals,
pubmed-meshheading:19694557-Arachidonate 15-Lipoxygenase,
pubmed-meshheading:19694557-Diabetic Retinopathy,
pubmed-meshheading:19694557-Gene Therapy,
pubmed-meshheading:19694557-Genetic Vectors,
pubmed-meshheading:19694557-Humans,
pubmed-meshheading:19694557-Ligands,
pubmed-meshheading:19694557-Macular Degeneration,
pubmed-meshheading:19694557-Mice,
pubmed-meshheading:19694557-Neovascularization, Pathologic,
pubmed-meshheading:19694557-Optic Disk,
pubmed-meshheading:19694557-PPAR gamma,
pubmed-meshheading:19694557-Rabbits,
pubmed-meshheading:19694557-Retinal Vessels,
pubmed-meshheading:19694557-Vascular Endothelial Growth Factor A,
pubmed-meshheading:19694557-Vascular Endothelial Growth Factor Receptor-2
|
pubmed:year |
2009
|
pubmed:articleTitle |
Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes.
|
pubmed:affiliation |
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, FI-70211 Kuopio, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|